Medication Safety Issues
Sound-alike/look-alike issues:
Dinutuximab may be confused with daratumumab, denosumab, obinutuzumab, rituximab
High-alert medication:
This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.
